News
Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global ...
Pfizer's $43B Seagen deal strengthens its oncology portfolio, offsets patent cliffs, and offers 70%+ upside potential. See ...
Pfizer witnessed a dramatic 45.77% surge in trading volume, reaching a staggering 11.97 billion shares. Pfizer's stock price ...
S&P Global Inc. is looking to expand partnerships with artificial intelligence companies to make its data available to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback